|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Current evidence indicates that the physiological functions of inflammatory cells are highly sensitive to their microenvironment, which is partially determined by the inflammatory cells and their potential targets. In the present investigation, interactions between neutrophils, macrophages and muscle cells that may influence muscle cell death are examined. Findings show that in the absence of macrophages, neutrophils kill muscle cells in vitro by superoxide-dependent mechanisms, and that low concentrations of nitric oxide (NO) protect against neutrophil-mediated killing. In the absence of neutrophils, macrophages kill muscle cells through a NO-dependent mechanism, and the presence of target muscle cells causes a three-fold increase in NO production by macrophages, with no change in the concentration of inducible nitric oxide synthase. Muscle cells that are co-cultured with both neutrophils and macrophages in proportions that are observed in injured muscle show cytotoxicity through a NO-dependent, superoxide-independent mechanism. Furthermore, the concentration of myeloid cells that is necessary for muscle killing is greatly reduced in assays that use mixed myeloid cell populations, rather than uniform populations of neutrophils or macrophages. These findings collectively show that the magnitude and mechanism of muscle cell killing by myeloid cells are modified by interactions between muscle cells and neutrophils, between muscle cells and macrophages and between macrophages and neutrophils.
This article has been cited by other articles:
![]() |
L. Yahiaoui, D. Gvozdic, G. Danialou, M. Mack, and B. J. Petrof CC family chemokines directly regulate myoblast responses to skeletal muscle injury J. Physiol., August 15, 2008; 586(16): 3991 - 4004. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wehling-Henricks, S. Sokolow, J. J. Lee, K. H. Myung, S. A. Villalta, and J. G. Tidball Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy Hum. Mol. Genet., August 1, 2008; 17(15): 2280 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tidball and M. Wehling-Henricks The role of free radicals in the pathophysiology of muscular dystrophy J Appl Physiol, April 1, 2007; 102(4): 1677 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marsolais, C. H. Cote, and J. Frenette Pifithrin-{alpha}, an inhibitor of p53 transactivation, alters the inflammatory process and delays tendon healing following acute injury Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R321 - R327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tidball and M. Wehling-Henricks Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo J. Physiol., January 1, 2007; 578(1): 327 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. X. Nguyen, A. J. Lusis, and J. G. Tidball Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo J. Physiol., June 1, 2005; 565(2): 403 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tidball Inflammatory processes in muscle injury and repair Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R345 - R353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. GROUNDS and J. TORRISI Anti-TNF{alpha} (Remicade(R)) therapy protects dystrophic skeletal muscle from necrosis FASEB J, April 1, 2004; 18(6): 676 - 682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |